These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 15160342

  • 21. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
    Le T, Alshaikh G, Hopkins L, Faught W, Fung MF.
    Ann Surg Oncol; 2006 Dec; 13(12):1711-6. PubMed ID: 17009146
    [Abstract] [Full Text] [Related]

  • 22. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
    Colitti CV, Rodabaugh KJ, Welch WR, Berkowitz RS, Mok SC.
    Oncogene; 1998 Jan 29; 16(4):555-9. PubMed ID: 9484846
    [Abstract] [Full Text] [Related]

  • 23. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R.
    Gynecol Oncol; 2006 Dec 29; 103(3):831-40. PubMed ID: 16919315
    [Abstract] [Full Text] [Related]

  • 24. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC.
    Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529
    [Abstract] [Full Text] [Related]

  • 25. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma].
    Yang YQ, Li JC.
    Ai Zheng; 2006 Jun 01; 25(6):713-7. PubMed ID: 16764766
    [Abstract] [Full Text] [Related]

  • 26. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T, Shigemasa K, Arihiro K, Fujii T, Nagai N, Ohama K.
    Oncol Rep; 2005 Jun 01; 13(6):1153-8. PubMed ID: 15870936
    [Abstract] [Full Text] [Related]

  • 27. p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months.
    Geisler JP, Geisler HE, Miller GA, Wiemann MC, Zhou Z, Crabtree W.
    Gynecol Oncol; 2000 May 01; 77(2):278-82. PubMed ID: 10785478
    [Abstract] [Full Text] [Related]

  • 28. c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome.
    Bagnoli M, Ambrogi F, Pilotti S, Alberti P, Ditto A, Barbareschi M, Galligioni E, Biganzoli E, Canevari S, Mezzanzanica D.
    Endocr Relat Cancer; 2009 Jun 01; 16(2):443-53. PubMed ID: 19321593
    [Abstract] [Full Text] [Related]

  • 29. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT, Fu L, Xia JC, Feng BJ, Mai SJ, Yu XJ, Huang LX, Feng QS, Pan ZZ, Zhan YQ.
    Ai Zheng; 2005 Nov 01; 24(11):1306-11. PubMed ID: 16552953
    [Abstract] [Full Text] [Related]

  • 30. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
    Dion F, Mes-Masson AM, Seymour RJ, Provencher D, Tonin PN.
    Oncogene; 2000 Mar 09; 19(11):1466-72. PubMed ID: 10723138
    [Abstract] [Full Text] [Related]

  • 31. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN, Presneau N, Provencher D, Mes-Masson AM, Tonin PN.
    Mol Carcinog; 2002 Jun 09; 34(2):78-90. PubMed ID: 12112314
    [Abstract] [Full Text] [Related]

  • 32. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ, Qin LX, Ren N, Hei ZY, Ye QH, Jia WD, Sun BS, Lin GL, Liu DY, Liu YK, Tang ZY.
    Clin Cancer Res; 2007 Dec 15; 13(24):7363-9. PubMed ID: 18094418
    [Abstract] [Full Text] [Related]

  • 33. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
    Borgoño CA, Kishi T, Scorilas A, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP.
    Clin Cancer Res; 2006 Mar 01; 12(5):1487-93. PubMed ID: 16533772
    [Abstract] [Full Text] [Related]

  • 34. Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.
    Gershenson DM, Deavers M, Diaz S, Tortolero-Luna G, Miller BE, Bast RC, Mills GB, Silva EG.
    Clin Cancer Res; 1999 Dec 01; 5(12):4053-8. PubMed ID: 10632339
    [Abstract] [Full Text] [Related]

  • 35. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
    Utada Y, Haga S, Kajiwara T, Kasumi F, Sakamoto G, Nakamura Y, Emi M.
    Cancer; 2000 Mar 15; 88(6):1410-6. PubMed ID: 10717624
    [Abstract] [Full Text] [Related]

  • 36. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining.
    Kritpracha K, Hanprasertpong J, Chandeying V, Dechsukhum C, Geater A.
    J Obstet Gynaecol Res; 2005 Jun 15; 31(3):268-76. PubMed ID: 15916666
    [Abstract] [Full Text] [Related]

  • 37. Prognostic impact of additional extended surgical procedures in advanced-stage primary ovarian cancer.
    Kommoss S, Rochon J, Harter P, Heitz F, Grabowski JP, Ewald-Riegler N, Haberstroh M, Neunhoeffer T, Barinoff J, Gomez R, Traut A, du Bois A.
    Ann Surg Oncol; 2010 Jan 15; 17(1):279-86. PubMed ID: 19898901
    [Abstract] [Full Text] [Related]

  • 38. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?
    Skirnisdottir I, Nordqvist S, Sorbe B.
    Oncol Rep; 2005 Aug 15; 14(2):521-9. PubMed ID: 16012740
    [Abstract] [Full Text] [Related]

  • 39. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC, Lin JK, Lin TC, Liang WY.
    Int J Oncol; 2005 Jan 15; 26(1):65-75. PubMed ID: 15586226
    [Abstract] [Full Text] [Related]

  • 40. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
    Mustea A, Pirvulescu C, Könsgen D, Braicu EI, Yuan S, Sun P, Lichtenegger W, Sehouli J.
    Cytokine; 2008 Apr 15; 42(1):77-84. PubMed ID: 18329282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.